Cart
sales@molnova.com
DHFR-IN-4
DHFR-IN-4
Catalog No. M35563
DHFR-IN-4 is a potent dihydrofolate reductase (DHFR) inhibitor with anti-tumor activity, which also inhibits EGFR and HER2, and is useful for studying pancreatic cancer.
| Size | Price / USD | Stock | Quantity |
| 2MG | 476 | Get Quote |
|
| 5MG | 748 | Get Quote |
|
| 10MG | 943 | Get Quote |
|
| 25MG | 1187 | Get Quote |
|
| 50MG | 1628 | Get Quote |
|
| 100MG | 2151 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDHFR-IN-4
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Sabry MA, et al. New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. Eur J Med Chem. 2022 Aug 10;241:114661.?
molnova catalog
related products
-
Methotrexate Digluta...
Methotrexate Diglutamate Small molecule compound present in the liver that acts as a partially purified human dihydrofolate reductase inhibitor.
-
DHFR-IN-4
DHFR-IN-4 is a potent dihydrofolate reductase (DHFR) inhibitor with anti-tumor activity, which also inhibits EGFR and HER2, and is useful for studying pancreatic cancer.
-
Fanotaprim
Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor. Fanotaprim inhibits the growth of T. gondii strains with a TgDHFR IC50 of 1.57 ± 0.11 nM and a hDHFR IC50 of 308?±?71 nM and a hDHFR to TgDHFR selectivity ratio of 196.
